Fast CompanyStem cell company Forever Labs attracts $2 mlnPE Hub (blog)Forever Labs, a company that banks young adult stem cells, has secured $2 million in funding. The investors included Northwestern Mutual, Silicon Badia Ventures, Babel Ventures and … Continue reading
Fast CompanyA startup that wants to cryogenically freeze your stem cells just snagged new fundingFast CompanyThe sector devoted to longevity and combatting aging is, well, maturing. Forever Labs, a startup that extracts and stores stem cells, just rece… Continue reading
IAM (blog) |
The top 10 CRISPR patent assignees at the world’s big five issuing agencies revealed
IAM (blog) The USPTO is the most willing of the major patent offices to grant CRISPR-related patents, but activity in the field is increasing most rapidly in Asia, new research commissioned for IAM reveals. Earlier this year, iRunway produced a report on the … CRISPR dust-up; compulsory licensing in China; Novartis CEO wants US reform, and more April’s Life Sciences IP …Lexology |
IAM (blog) |
The top 10 CRISPR patent assignees at the world’s big five issuing agencies revealed
IAM (blog) The USPTO is the most willing of the major patent offices to grant CRISPR-related patents, but activity in the field is increasing most rapidly in Asia, new research commissioned for IAM reveals. Earlier this year, iRunway produced a report on the … CRISPR dust-up; compulsory licensing in China; Novartis CEO …Lexology |
Wall Street Journal |
Eli Lilly Buys Immunotherapy Cancer Treatment Company for $1.6 Billion
Wall Street Journal Immunotherapy, or immune-cell therapy, describes a range of treatments that harness a patient’s own immune system to target cancer. The approach doesn’t work in all patients, but has worked well against hard-to-treat cancers in some and has become the … Eli Lilly acquires small biotech for $1.6B to strengthen cancer immunotherapy pipelineSTAT Lilly (LLY) to Acquire ARMO BioSciences (ARMO) for $50/ShareStreetInsider.com |
Healthline |
Stem Cell Treatments Provide Hope for Easing Back Pain
Healthline Now the 78-year-old is touting an experimental stem cell surgery that he says is more effective than anything else he’s tried. The surgery, under the guidance of German scientist and physician Eckhard Alt, was performed two years ago in Munich. The … |